StockNews.com Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a research note released on Saturday.

PAHC has been the topic of several other reports. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Morgan Stanley increased their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Barclays boosted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Trading Down 1.0 %

PAHC stock opened at $20.52 on Friday. The stock has a market cap of $831.12 million, a price-to-earnings ratio of 47.72, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. The company has a fifty day moving average price of $23.01 and a two-hundred day moving average price of $20.96. Phibro Animal Health has a one year low of $10.03 and a one year high of $25.98. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.34%. Phibro Animal Health’s payout ratio is 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. nVerses Capital LLC bought a new position in Phibro Animal Health in the third quarter valued at approximately $70,000. Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health in the 3rd quarter valued at $70,000. China Universal Asset Management Co. Ltd. increased its stake in shares of Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. CWM LLC raised its holdings in shares of Phibro Animal Health by 190.8% during the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after buying an additional 4,175 shares in the last quarter. Finally, Algert Global LLC bought a new stake in shares of Phibro Animal Health during the 2nd quarter worth $193,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.